INTERVIEW FEED & ADDITIVE MAGAZINE June 2025 57 It’s a phytogenic-based solution designed to promote feed intake and thereby support piglet resilience immediately post-weaning, when digestive and immune systems are underdeveloped and animals face stressors from new environments, diets, and pen mates. By promoting feed intake and supporting optimal gut functioning, animals become more resilient to these stressors leading to reduced need for antibiotic use. Cinergy™ Protect helps producers navigate this high-risk period with more confidence. But Cinergy™ is more than a single product. It’s our global brand for swine in our portfolio and a platform that will continue to expand in order to address needs across all swine life stages. It exemplifies our move toward species-centered, lifecycle-based solutions that pair deep science based, nutritional science with precise interventions in the animal diets. Looking ahead, what can we expect from the next phase of the Cargill MHS portfolio evolution? The reality is, we are just getting started and this is exciting. The next phase is about targeted innovation, both by extending our existing technologies into new regions and categories and by developing new solutions where we see unmet needs. Gut health and the microbiome will remain core pillars, but within MHS we are also focusing on integrating our digital tools and services to support our customers’ on-farm decision-making. Our roadmap includes a promising expansion of the Biostrong™ and Cinergy™ lines and continuing the introduction of the remaining species brands under the Cargill MHS business. Producers can expect innovations designed not just for today’s challenges but anticipating what’s coming next. Whether it’s antimicrobial resistance pressures, evolving sustainability goals, or changing consumer expectations. At the heart of it all is our commitment to micronutrition and health solutions that protect, preserve, and perform, driving transformative change for animal producers worldwide. It sounds like exciting times ahead for Cargill and your customers. Thank you for sharing these insights. Thank you! It’s an exciting journey, and we’re proud to be working alongside our customers to shape the future of animal nutrition together. About Dr. Christos Antipatis Christos Antipatis is the Global Micronutrition & Health Solutions (MHS) Director for Cargill Animal Nutrition & Health, where he is responsible for managing and advancing the MHS portfolio leading the innovation pipeline and seeking new partnerships that strengthen our portfolio. Antipatis joined Cargill in 2016 as Global Technology Director and since then, has held various global strategic marketing and technology roles. Before joining Cargill, he worked at DSM Nutritional Products for 15 years, holding various global and regional roles in marketing, innovation and other business/technical positions. Antipatis has an undergraduate degree in agricultural engineering with specialization in animal science from the Agricultural University of Athens in Greece. He earned a Master of Science in Animal Nutrition and, subsequently, a Doctor of Philosophy (PhD) in Nutrition and Reproduction from the University of Aberdeen, UK. In addition, he spent three years doing nutrition-related scientific research at the Rowett Research Institute. Christos Antipatis lives with his wife, son and daughter in Edinburgh, Scotland. He enjoys walking, exercising, reading, and travelling, particularly back to his home country Greece. He is a wine and whisky enthusiast and has developed a passion for watching rugby. Photo: Courtesy of Cargill
RkJQdWJsaXNoZXIy MTUxNjkxNQ==